Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours.

Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: A cross-sectional study

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease

Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine

Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India

Sensitization to trometamol in patients with delayed local reactions after administration of the Moderna mRNA-1273 vaccine against SARS-CoV-2

Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations

Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2014–15 Influenza Season

Comment on “Gut-associated lymphoid tissue contains the molecular machinery to support T-cell-dependent and T-cell-independent class switch recombination”

Rapid COVID-19 vaccine rollout: immense success but challenges ahead

Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients

A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19

COVID-19 vasculitis and novel vasculitis mimics.

The immunology of COVID-19: is immune modulation an option for treatment?

Outcome of Endovascular Treatment of Acute Type B Aortic Dissection